Accent Microcell Ltd (NSE:ACCENTMIC) Share Price

Company Profile

Business description
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
Contact
Shyamal Cross Roads, Anandnagar Road
314, Shangrilla Arcade
Satellite
AhmedabadGJ380015
IND
T: +91 7940042367
https://www.accentmicrocell.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
192

Recommended

Wide moat Eli Lilly receives FDA approval for obesity pill.

Karen Andersen, CFA | 02 April 2026

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.

Simonelle Mody | 02 April 2026

OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.

Harrison Rolfes | 02 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,774.90	124.80	-1.40%
CAC 40	7,981.27	164.33	2.10%
DAX 40	23,298.89	618.85	2.73%
Dow JONES (US)	46,565.74	224.23	0.48%
FTSE 100	10,364.79	188.34	1.85%
HKSE	24,960.25	333.78	-1.32%
NASDAQ	21,840.95	250.32	1.16%
Nikkei 225	52,444.58	1,295.10	-2.41%
NZX 50 Index	12,902.15	76.28	0.59%
S&P 500	6,575.32	46.80	0.72%
S&P/ASX 200	8,579.50	105.50	-1.21%
SSE Composite Index	3,915.01	33.54	-0.85%